A Quercetin Containing Supplement Reduces Niacin-Induced Flush in Humans

@article{Kalogeromitros2008AQC,
  title={A Quercetin Containing Supplement Reduces Niacin-Induced Flush in Humans},
  author={D Kalogeromitros and Michael P. Makris and C Chliva and Xenophon Aggelides and D. Kempuraj and Theoharis C. Theoharides},
  journal={International Journal of Immunopathology and Pharmacology},
  year={2008},
  volume={21},
  pages={509 - 514}
}
Coronary artery disease is associated with increased serum levels of cholesterol, triglycerides and LDL, but low levels of HDL. The most potent agent capable of reversing this trend is the vitamin nicotinic acid (niacin). However, compliance even with extended-release preparations and addition of acetylsalicylic acid (ASA) is hampered by the development of a feeling of erythema and burning (“flush”), especially on the face. We recently showed that the natural flavonoids quercetin and luteolin… 

Figures from this paper

NIACIN AND NIACIN / LAROPIPRANT COMBINATION: OPENING NEW HOPES FOR DYSLIPIDEMIA AND CARDIOVASCULAR DISEASES WITH FEW NOVEL ACTIONS
TLDR
Novel actions of niacin in immune system improves peripheral mononuclear cells cell viability, decrease in genotoxic stress, drug for hyperphosphatemia, improvement in symptoms of Parkinsonism and psoriasis, and the combination of ERN and Laropiprant in reducing overall risk of cardiovascular diseases is discussed in detail.
Important Considerations for Treatment with Dietary Supplement versus Prescription Niacin Products
TLDR
Current regulatory standards for dietary supplements and prescription drugs are contrasted and an overview of available clinical data from key trials of niacin is provided.
A "hot" topic in dyslipidemia management--"how to beat a flush": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention.
TLDR
Through effective counseling, treatment prophylaxis with aspirin, and careful dose escalation, adherence to niacin treatment can be improved significantly.
A Review on the Antioxidative and Prooxidative Properties of Luteolin
TLDR
This mini-review briefly summarizes the established beneficial effect of luteolin with regard to the maintenance of balance between pro- and anti-oxidation.
Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics[S]
TLDR
Objective, quantitative, and unbiased methods measuring NASTy stigmata are presented to facilitate research into novel niacin mimetics/analogs, detailing characteristics of each technique following niacIn, and how NASTyStigmata relate to symptom perception.
Reappraisal of Dietary Phytochemicals for Coronavirus Infection: Focus on Hesperidin and Quercetin
TLDR
This chapter draws attention to certain nutritional components such as hesperidin and quercetin, which are emerging as good candidates for a complementary beneficial effect in the case of diseases caused by viruses, including COVID-19.
ESTERIFICATION OF NATURAL COMPOUNDS WITH FATTY ACIDS
TLDR
This PhD project synthesized esters of β-sitosterol, resveratrol and quercetin, three natural substances featuring ascertained biological activities characterized by a limited bioavailability and a low stability, and incorporated in liposome formulations to improve drug topical delivery.
Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials
  • A. Sahebkar
  • Medicine
    Critical reviews in food science and nutrition
  • 2017
TLDR
Available evidence from RCTs does not suggest any clinically relevant effect of quercetin supplementation on plasma lipids, apart from a significant reduction of triglycerides at doses above 50 mg/day.
The potential of natural products as effective treatments for allergic inflammation: implications for allergic rhinitis.
  • M. Kulka
  • Biology
    Current topics in medicinal chemistry
  • 2009
TLDR
The molecular mechanisms and scientific validity of some herbal remedies currently used clinically in the treatment of allergic rhinitis will be explored and mast cells and their mediators are focused on.
...
...

References

SHOWING 1-10 OF 36 REFERENCES
Varying Cost and Free Nicotinic Acid Content in Over-the-Counter Niacin Preparations for Dyslipidemia
TLDR
Broad-ranging effects make nicotinic acid an effective tool in the treatment of most lipid disorders, including dyslipidemia of the metabolic syndrome, and one reason for its underuse is the side effects.
The flavonoid luteolin inhibits niacin‐induced flush
TLDR
This work investigated whether niacin‐induced flush in a rat model involves PGD2 and 5‐HT, and the effect of certain flavonoids, and how this affects serum cholesterol, LDL and triglycerides, while raising HDL.
Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad‐spectrum lipid drug
  • L. Carlson
  • Medicine, Biology
    International journal of clinical practice
  • 2004
TLDR
Niacin, now available as the well‐tolerable drug formulation Niaspan™, is the unique broad‐spectrum lipid drug for the prevention and treatment of clinical atherosclerosis.
New perspectives on the use of niacin in the treatment of lipid disorders.
TLDR
Niacin-induced changes in serum lipid levels produce significant improvements in both coronary artery disease and clinical outcomes, and is ideal for treating a wide variety of lipid disorders, including the metabolic syndrome, diabetes mellitus, isolated low high-density lipoprotein cholesterol, and hypertriglyceridemia.
The effect of aspirin on niacin-induced cutaneous reactions.
TLDR
It appears from this pilot study that preceding niacin with 325 mg of aspirin will decrease the warmth and flushing associated with niacing, and this could help improve patient acceptability and tolerability.
Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia.
TLDR
Once-daily once-daily PR nicotinic acid appears to maximise the potential benefits of nicotinIC acid, while minimising any historical tolerability or safety concerns.
Niacin therapy in atherosclerosis
TLDR
New data indicate that niacin alters lipoprotein metabolism in novel ways, and mediates other beneficial nonlipid changes that may be atheroprotective, forming the rationale for the use of niac in combination with agents possessing complementary mechanisms of action for cardiovascular risk reduction beyond that observed with monotherapy.
Safety considerations with niacin therapy.
...
...